Chancellor Rachel Reeves Plans Specific Measures on Household Expenses in Upcoming Budget
Chancellor Rachel Reeves has stated she is preparing "focused steps to tackle household expense pressures" in next month's financial statement.
Speaking to the BBC, she stated that reducing inflation is a collective task of both the administration and the central bank.
The UK's price growth is projected to be the most elevated among the G7 industrialized countries this year and the following year.
Potential Utility Cost Measures
Sources suggest the administration could take action to lower energy bills, for example by slashing the current 5% rate of VAT applied on energy.
An additional option is to lower some of the regulatory levies presently included in household expenses.
Fiscal Limitations and Expert Expectations
The administration will obtain the next assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much room there is for these measures.
The expectation from the majority of economists is that the Chancellor will have to announce tax increases or expenditure reductions in order to meet her self-imposed borrowing rules.
Earlier on the same day, estimates indicated there was a £22bn deficit for the chancellor to fill, which is at the lower end of forecasts.
"There's a joint responsibility between the Bank of England and the administration to continue tackling some of the drivers of price increases," the Chancellor stated to reporters in the US capital, at the yearly gatherings of the IMF and World Bank.
Tax Pledges and International Issues
While much of the attention has been on expected tax increases, the Treasury chief said the most recent information from the OBR had not changed her commitment to manifesto promises not to increase rates on earnings tax, sales tax or social security contributions.
She blamed an "unpredictable world" with increasing geopolitical and commercial tensions for the Budget tax moves, probably to be targeted on those "wealthiest."
International Trade Disputes
Referring to concerns about the United Kingdom's economic relations with the Asian nation she said: "Our national security always come first."
Recent statement by China to increase trade restrictions on rare earths and other materials that are key for high-technology manufacturing led American leader the US President to propose an extra 100% tariff on imports from China, increasing the possibility of an full-scale commercial conflict between the two largest economies.
The American finance chief labeled the Chinese action "economic coercion" and "a international production control attempt."
Asked about accepting the US offer to join its conflict with China, the Chancellor said she was "deeply worried" by Chinese actions and called on the Chinese government "not to put up barriers and limit trade."
She said the decision was "bad for the global economy and generates further headwinds."
"It is my opinion there are fields where we should confront Chinese policies, but there are also important prospects to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to get that equilibrium correct."
The chancellor also confirmed she was cooperating with international partners "on our own critical minerals plan, so that we are more independent."
NHS Drug Pricing and Investment
Reeves also acknowledged that the price the National Health Service spends on drugs could rise as a consequence of current discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and investment.
A number of the world's largest pharmaceutical manufacturers have said lately that they are either halting or abandoning investments in the UK, with several attributing the insufficient payments they are getting.
Recently, the Science Minister said the price the NHS spends on drugs would need to increase to stop companies and drug research funding leaving the United Kingdom.
Reeves stated to the BBC: "It has been observed because of the pricing regime, that medical research, innovative medicines have not been provided in the UK in the manner that they are in other EU nations."
"We want to ensure that patients getting treatment from the National Health Service are can access the finest essential medicines in the globe. And so we are reviewing this situation, and... looking to secure increased investment into Britain."